Mnc Pharma Firms

Legacy pharma brands spin gold for GSK, Pfizer; keep newcomers off the turf

Repositioning an old brand helps expand the footprint, say analysts

MNCs, domestic drug makers did equally well in terms of growth rate

The data shows that in the last 12 months, multinational drugmakers have also done equally well in the Indian market in terms of growth rate

MNC pharma shares in focus; Pfizer, Sanofi India, AstraZeneca hit new high

Novartis India rallied 7 per cent to Rs 709, while Abbott India gained 2 per cent to Rs 12,865 on the BSE.

Three key reasons why CLSA is bullish on pharma MNCs in India

MNC stocks have outperformed local peers for the first time in over a decade and have also significantly outperformed the Nifty over the last 18 months.

Despite price control measures, multinational medical firms fare well

Indian companies importing their devices from abroad still remains only around 20 per cent of the total imports